Home
Stina Singel, Officer, EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY: Ascendis Pharma A/S ASND Planned sale · Filed 25/02/21
Trade details
- Type
- Planned sale notice
- Planned sale date
- 25/02/20
- Filed
- 25/02/21
More to sell after $273.6K in 3 months
Ascendis Pharma A/S trades, last 26 weeks
What else happened in Ascendis Pharma A/S around then
Filed or reported within 30 days of the trade day · 25/01/21~25/03/22Stina Singel's recent trades
- Stina Singel
Planned saleAscendis Pharma A/S
Planned saleAscendis Pharma A/S
ASND
$907.7K
3,782 sh
$907.7K
Filed 03/09
Traded 03/09
- Stina Singel
Planned saleAscendis Pharma A/S
Planned saleAscendis Pharma A/S
ASND
$45.7K
218 sh
$45.7K
Filed 25/12/01
Traded 25/12/01
- Stina Singel
Planned sale10b5-1 planAscendis Pharma A/S
Planned sale10b5-1 planAscendis Pharma A/S
ASND
$2M
13,344 sh
$2M
Filed 25/03/04
Traded 25/03/04